Organogenesis, Inc. disclosed in its 10-K Item 1C that it has experienced cybersecurity threats, including malware and computer virus attacks, but states these have not materially affected its business strategy, results of operations, or financial condition. The company maintains cybersecurity infrastructure, partners with third-party vendors for monitoring and penetration testing, and has governance oversight via its Audit Committee.